Antibody-based cancer therapeutics biotech
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 80 | New buy | 686,577 | $1,503,604 | 0.0% |
| Paul Tudor Jones / Tudor | 63 | Added +1% | 90,044 | $197,196 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-17.